We provide actionable answers from pre-clinical to post-launch. What can Norstella help you with? https://ow.ly/acO550PQWIE #Pipeline2Patient #Answers4Pharma #Pharma Citeline, Evaluate Ltd, MMIT (Managed Markets Insight & Technology), Panalgo, The Dedham Group
Norstella
Information Services
Yardley, PA 50,517 followers
We're on a mission to improve patient access to therapy.
About us
Norstella is a group of prominent pharmaceutical solutions providers – Citeline, Evaluate, MMIT, Panalgo, The Dedham Group – that help clients navigate complexities at each step of the drug development life cycle, from pipeline to patient.
- Website
-
http://www.norstella.com
External link for Norstella
- Industry
- Information Services
- Company size
- 1,001-5,000 employees
- Headquarters
- Yardley, PA
- Type
- Privately Held
Locations
-
Primary
Yardley, PA 19067, US
Employees at Norstella
Updates
-
Obesity has become a major global concern due to its increased prevalence and life-threatening comorbidities. As a result, there has been a rise in competition in this sector, with life sciences organizations recognizing the potential of new treatment methods for this chronic disease. Norstella supports stakeholders involved in obesity drug development by providing reliable industry data and expert insights. Our exclusive infographic illustrates the complex factors influencing obesity research and development, future expectations for this growing market, and how Norstella can assist organizations in delivering life-saving treatments to patients. Download the infographic here: https://ow.ly/zZ8t50S7hHI #Norstella #Pipeline2Patient #Obesity
-
Cell and gene therapies (C>s) experienced a landmark close to 2023 and maintained momentum into Q1 2024. https://lnkd.in/gJcBNkA9 According to the latest quarterly Gene, Cell & RNA Therapy Landscape Report by Citeline in association with the American Society of Gene & Cell Therapy (ASCGT), this period saw several notable approvals and strong growth across all stages of clinical development. Click the link in this post to learn more about the current evolution of cell therapy. #Pipeline2Patient #FollowNorstella
-
Employee Spotlight Series: Meet Michelle Marwah! https://ow.ly/IckL50T9PyO We’re excited to highlight Michelle Marwah, our amazing VP of Operations at Norstella’s Gurgaon site near New Delhi, India! 🇮🇳 Michelle is the driving force behind our operations and HR, ensuring everything runs smoothly, and our team thrives. Her leadership and dedication are truly inspiring! Want to know more about Michelle’s journey and impact at Norstella? Click the link above to read her story and see why she’s such a valuable member of our team. #Pipeline2Patient #FollowNorstella
-
Take our survey and help shape the future of AI in drug R&D!: https://ow.ly/9FH550SRwoX. Participants who complete the survey will be offered the option to enter a draw to win one of four $/€/£100 Amazon gift vouchers! Norstella is cutting through the hype to explore the real-world impact of advanced technologies on developing new treatments for patients. We want your valuable insights on AI's current applications, challenges, and future innovations in the pharmaceutical industry. By participating, you’ll contribute to Norstella’s thought leadership content, helping to inform and improve the development of new treatments for patients in need. #Pipeline2Patient #FollowNorstella #Pharma #Survey
-
How will the recent FDA diversity-focused draft guidance impact clinical outcomes in the future? Lya Rebelo, Commercial Enablement Manager at Citeline, discusses this in a recent interview with Janelle Hart. Read the exclusive insights: https://ow.ly/prAz50SNnyt.
-
Norstella reposted this
Last year was a hot pharma year for new active substances (NASs), but there are a few rain clouds forecasted. Our reports, infographics, audiobook and webinar are here to help determine where the outlook is sunny and where clouds are forming: https://ow.ly/eaAa50Sl3mW.
-
Take our survey and help shape the future of AI in drug R&D!: https://ow.ly/PZlB50SRwoc. Participants who complete the survey will be offered the option to enter a draw to win one of four $/€/£100 Amazon gift vouchers! Norstella is cutting through the hype to explore the real-world impact of advanced technologies on developing new treatments for patients. We want your valuable insights on AI's current applications, challenges, and future innovations in the pharmaceutical industry. By participating, you’ll contribute to Norstella’s thought leadership content, helping to inform and improve the development of new treatments for patients in need. #Pipeline2Patient #FollowNorstella #Pharma #Survey
-
The latest quarterly Gene, Cell & RNA Therapy Landscape Report by Citeline and the association with the American Society of Gene & Cell Therapy highlights significant growth in cell and gene therapies. https://lnkd.in/gqBeJeNK With over 4,000 therapies in development, including a notable increase in Phase I, II, and III programs, the potential to address unmet medical needs is expanding rapidly. Oncology remains a key focus, but there's also seeing a rise in non-oncology applications. Click the link in this post to read the full article. #Pipeline2Patient #FollowNorstella